Atlas Trials

Borderline Resectable Pancreatic Adenocarcinoma

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Borderline Resectable Pancreatic Adenocarcinoma

RecordFirmDate
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer (NCT05356039)Umeå University2022-04-19
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer (NCT04940286)M.D. Anderson Cancer Center2021-09-28
Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma (NCT04915417)London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2021-08-01
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer (NCT04669197)HonorHealth Research Institute2020-12-01
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer (NCT04106856)University of Utah2019-08-08
Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer (NCT03970252)Jonsson Comprehensive Cancer Center2019-07-24
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2) (NCT04423731)Oslo University Hospital2018-01-01
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer (NCT02394535)M.D. Anderson Cancer Center2015-11-12
Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma (NCT02446093)Candel Therapeutics, Inc.2015-10-01

Track Borderline Resectable Pancreatic Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.